Prevalence, detection, and management of the metabolic syndrome in patients with acute myocardial infarction: role of an obesity-centric definition.
Background. We sought to determine and compare the prevalence of the Metabolic Syndrome (MS) in patients with acute myocardial infarction (AMI) utilizing the new International Diabetes Federation (IDF) definition with the older National Cholesterol Education Program (NCEP) definition. We also examined the clinical utility of MS in this context. Methods. A total of 107 consecutive patients with AMI were prospectively evaluated for MS. Fasting lipids obtained at admission and fasting glucose at discharge were used. A postdischarge folder audit verified rates of discharge coding and implementation of specific management strategies for MS. Results. Baseline patient characteristics included: mean age 59 +/- 13 years; males 80%; diabetes 19%; mean BMI 29.7 +/- 8.4 kg/m(2). MS prevalence was 54% by the IDF definition and 49% by the NCEP definition, with good agreement between definitions: kappa = 0.664, P < .001. Factors predictive of MS after multivariate analysis included: hypertension, fasting glucose, waist circumference, and serum HDL (all P < .05). Despite the high prevalence, MS was recognized at discharge in only 1 patient, and referral for exercise and/or weight-loss programs was undertaken in 5 patients. Conclusion. There is a high prevalence of MS utilizing contemporary definitions in patients with AMI: 54% by the IDF definition and 49% by NCEP criteria. Despite the high prevalence, MS was under-recognized and under-treated in this population.
Prasad
Sandhir B
SB
Monash Heart and Monash Cardiovascular Research Centre, Monash Medical Centre, 246 Clayton Road, Clayton, Melbourne, Victoria 3168, Australia.
Fahrtash
Farzan
F
Malaiapan
Yuvaraj
Y
Meredith
Ian T
IT
Cameron
James
J
Diabetes Res Clin Pract. 2007 Sep;77(3):471-8
17350710
Lancet. 2005 Sep 24-30;366(9491):1059-62
16182882
Med J Aust. 2006 Apr 17;184(S8):S1-S32
16618231
J Clin Endocrinol Metab. 2005 Jan;90(1):175-80
15509644
Am J Cardiol. 2002 Feb 15;89(4):460-2
11835930
Diabetes Care. 2001 Apr;24(4):683-9
11315831
J Am Coll Cardiol. 2004 Aug 4;44(3):671-719
15358045
BMJ. 2008 Mar 22;336(7645):640
18356231
Arterioscler Thromb Vasc Biol. 2008 Apr;28(4):629-36
18174459
JAMA. 2001 May 16;285(19):2486-97
11368702
Diabet Med. 2006 May;23(5):469-80
16681555
Circulation. 2007 Apr 3;115(13):1806-10; discussion 1811
17404171
Diabetes Care. 2004 Jan;27 Suppl 1:S15-35
14693923
Am J Cardiol. 2007 Oct 1;100(7):1052-5
17884360
Br Med J (Clin Res Ed). 1984 Dec 15;289(6459):1651-3
6439361
Diabetes Care. 2003 Oct;26(10):2770-6
14514578
Diabetes Res Clin Pract. 2008 Jan;79(1):91-6
17919764
N Z Med J. 2006 Dec 15;119(1247):U2372
17195862
Circulation. 2004 Sep 7;110(10):1251-7
15326061
Diabetes. 1988 Dec;37(12):1595-607
3056758
World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253
11234459